Trypanosoma brucei
Parasite causing sleeping sickness and nagana in sub-Saharan Africa.
Trypanosoma brucei is a parasitic kinetoplastid from the genus Trypanosoma, found only in sub-Saharan Africa. It causes two deadly vector-borne diseases: African trypanosomiasis, or sleeping sickness, in humans, and animal trypanosomiasis, known as nagana, in cattle and horses. Unlike most protozoan parasites, which invade blood or tissue cells, T. brucei stays entirely outside cells, living in blood plasma and other body fluids.
This parasite is actually a species complex made up of five subspecies: T. b. brucei, T. b. equiperdum, T. b. evansi, T. b. gambiense, and T. b. rhodesiense. The first infects non-human mammals and causes nagana. The last two are zoonotic, meaning they can infect both humans and animals, leading to African trypanosomiasis. Tsetse flies (Glossina species) transmit T. brucei between mammal hosts through bites during blood meals. As the parasite moves between insect and mammal, it undergoes complex changes in shape and form. In the mammalian bloodstream, its surface is covered with variant surface glycoproteins, which allow it to constantly change its appearance—a trick called antigenic variation—so the host’s immune system can’t catch up, leading to a long-lasting chronic infection. T. brucei is one of the few pathogens that can cross the blood-brain barrier. Current treatments can have severe side effects and even be fatal, so new drugs are urgently needed.
Although T. b. equiperdum and T. b. evansi were not historically considered subspecies of T. brucei because they spread differently, cause different symptoms, and have lost their kinetoplast DNA, genetic studies show they evolved from parasites very similar to T. b. brucei and are now thought to belong to the brucei clade.
The parasite was discovered in 1894 by Sir David Bruce, and the scientific name was given in 1899.
- field
- Parasitology, tropical medicine
- known_for
- Causing African trypanosomiasis (sleeping sickness) and nagana; antigenic variation via variant surface glycoproteins; crossing the blood-brain barrier
Lore & Background
*Trypanosoma brucei* is a parasitic kinetoplastid protozoan found exclusively in sub-Saharan Africa. Unlike many other protozoan parasites, it does not invade host cells but remains extracellular, inhabiting the blood plasma and other body fluids of its mammalian hosts. The parasite is transmitted between mammals through the bite of an infected tsetse fly, during which it undergoes complex morphological changes as it alternates between insect and mammalian life stages. In the mammalian bloodstream, the parasite is distinguished by its surface coat of variant surface glycoproteins, which undergo constant antigenic variation, allowing it to evade the host’s adaptive immune system and establish chronic infection. *T. brucei* is also one of the few pathogens capable of crossing the blood-brain barrier. The species comprises five subspecies: *T. b. brucei*, which infects non-human mammals and causes nagana; *T. b. gambiense* and *T. b. rhodesiense*, which are zoonotic and cause African trypanosomiasis (sleeping sickness) in humans; and *T. b. equiperdum* and *T. b. evansi*, which, despite differing in transmission and clinical presentation, are genetically derived from *T. b. brucei*. The parasite was discovered in 1894 by Sir David Bruce, after whom it was named in 1899.
Reader's Guide
Trypanosoma brucei is significant as the causative agent of African trypanosomiasis (sleeping sickness) in humans and nagana in animals, diseases that have caused major epidemics in sub-Saharan Africa. The parasite is transmitted by tsetse flies (Glossina) and undergoes complex morphological changes between insect and mammal hosts. Its mammalian bloodstream forms feature variant surface glycoproteins that undergo remarkable antigenic variation, enabling persistent evasion of host adaptive immunity and leading to chronic infection. T. brucei is one of only a few pathogens known to cross the blood-brain barrier. Current treatments can have severe side effects and can prove fatal, creating an urgent need for new drug therapies. The species complex includes five subspecies, with T. b. gambiense and T. b. rhodesiense causing human disease.
Did You Know?
- T. brucei is one of only a few pathogens known to cross the blood-brain barrier.
- The parasite undergoes complex morphological changes as it moves between insect and mammal hosts.
Frequently Asked Questions
Who is Trypanosoma brucei?
Trypanosoma brucei is a parasitic kinetoplastid protozoan endemic to sub-Saharan Africa that lives exclusively outside host cells, drifting freely in blood plasma and other body fluids. It is the causative agent of African trypanosomiasis (sleeping sickness) in humans and nagana in cattle and horses.
What are Trypanosoma brucei's powers/role?
Its signature trick is antigenic variation: it continuously swaps the glycoproteins on its surface coat to stay one step ahead of the host's antibodies. It can also breach the blood-brain barrier, a capability that very few other parasites possess and that makes the disease so lethal once the central nervous system is involved.
How does Trypanosoma brucei's story end?
Without treatment, the parasite invades the brain and triggers progressive neurological deterioration, culminating in the comatose stage of sleeping sickness and death. In livestock, the chronic nagana form slowly debilitates animals, slashing their productivity before eventually killing them.
How does Trypanosoma brucei differ from other protozoan parasites?
Whereas most protozoan pathogens hide inside red blood cells or tissue cells, T. brucei is strictly extracellular, spending its entire parasitic phase suspended in plasma and bodily fluids. That open, cell-free lifestyle is precisely what forces it to develop its elaborate antigenic-variation machinery to survive relentless immune attacks.
More in Microbial Pathogens 1-20
Spotted an error? Know more?
This is a living reference — every entry is fact-audited, and reader corrections feed straight into our audit queue. Suggest an edit · See this site's audit record